인디애나의 제2형 당뇨병 임상 시험
제2형 당뇨병 관련 연구 18개가 인디애나 내 여러 지역에서 참여자를 모집하고 있습니다.
인디애나의 도시
공식 연구 텍스트(영어)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- American Health Network - Avon, Avon
- Midwest Cardiovascular Research and Education Foundation, Elkhart
- American Health Network - Greenfield, Greenfield
- 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07064473A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07783802A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Indiana Medical Research Institute, Indianapolis
- Franciscan Physician Network- Indiana Heart Physicians, Indianapolis
피험자 모집 중건강한 지원자 환영
55세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- MediSphere Medical Research Center, LLC, Evansville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07595549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- DM Clinical Research - Indianapolis, Indianapolis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07282600A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Evansville
- AURORA-2 Clinical Site, Indianapolis
- AURORA-2 Clinical Site, Valparaiso
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- AES - DRS - Synexus Clinical Research US, Inc. - Evansville, Evansville
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07340320A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Investigators Research Group, Brownsburg
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06897475A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Midwest Inst For Clin Res, Indianapolis
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT07668388A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Riley Hospital For Children, Indianapolis
피험자 모집 중3상
10세 ~ 18세 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07282613A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Evansville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07662213AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- American Health Network of IN LLC_Franklin, Franklin
- American Health Network of Indiana, LLC_Greenfield, Greenfield
- American Health Network of IN LLC, Muncie
피험자 모집 중3상
45세 이상 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Evansville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT07662109Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- The South Bend Clinic, South Bend
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT07527650A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Center for Diabetes and Metabolic Diseases Indiana University, Indianapolis
피험자 모집 중3상
10세 ~ 17세 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06739122Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Indiana University, Indianapolis
피험자 모집 중
14세 ~ 75세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT07579702Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Indiana University, Bloomington
피험자 모집 중
18세 ~ 75세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT07521475Drug Interaction Potential of Pro-Inflammatory Conditions
- Indiana University Hospital, Indianapolis
피험자 모집 중관찰 연구
12세 ~ 99세 · 모든 성별 · 2026. 1. 22. 업데이트됨 · NCT07360938ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.